Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Venous thromboembolism in 5-year cancer survivors: a nationwide cohort study.

A. Yafasova Guo-Li Sun M. Hutchings S. Doi M. Schou M. Maraldo A. Alhakak N. Nouhravesh J. McMurray M. Petrie Ni-Nian N. Lang L. Køber E. Fosbøl J. Butt
Aug 2026 · European Journal of Preventive Cardiology · 0 citations
Medicine

TL;DR

Survivors of all 21 cancer subtypes had a higher associated rate of VTE compared with the background population, with the highest incidence rates found for multiple myeloma.

DOI PubMed Semantic Scholar
View source

Similar papers

Open access Sep 2026

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study.

Survivors of childhood cancer are at risk of adverse sequelae related to prior therapies. We describe the prevalence of and risk factors for late (≥5 years from cancer diagnosis) venous thromboembolism (VTE) among participants of the St. Jude Lifetime Cohort (N=5229). Prevalence of late VTE was compared between survivo...

R. Jesudas, Lei Wang, Yan Chen et al. · 0 citations
Sep 2026

Venous thromboembolism mortality trends among us adults with cancer, 1999-2024.

VTE-related mortality among US adults nearly doubled from 1999 to 2024, followed by stabilization after 2022, and persistent disparities across demographic and geographic subgroups underscore the urgent need for equity-oriented prevention strategies.

Gang Li, Xue Zhang, Guan-Bo Zhang et al. · 0 citations
Aug 2026

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

OBJECTIVES We aim to describe the venous thromboembolism (VTE) rate among patients who received chemotherapy for initial endometrial cancer treatment, and identify factors associated with VTE diagnosis in this population. METHODS This is a retrospective cohort study of patients who received chemotherapy during initia...

Elizabeth G. Thayer, Zoe A. Roecker, K. A. Roof et al. · 0 citations
Sep 2026

Cancer rarity and mortality: Evidence from a nationwide cohort study.

BACKGROUND Patients with rare cancers have consistently been reported to have poorer survival than patients with common cancers. We hypothesized that the excess mortality could be attributable to differences in tumor histology and stage at diagnosis and, explored whether it reflected a broader relationship between canc...

S. M. Kønig, S. Friis, T. Kjær et al. · 0 citations
Open access Oct 2026

Cumulative-incidence crossover and conditional mortality after definitive surgery for endometrial cancer: a population-based competing-risk analysis

Long-term survivors of endometrial cancer face competing risks from cancer and other conditions, but how these risks evolve remains uncertain. We conducted a population-based retrospective cohort study of 255,104 women who underwent hysterectomy-based definitive surgery for endometrial cancer in the Surveillance, Epi...

Rui-Cong Wang, Chuan-Jia Guo, Fang Tong · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.